For patients who had baseline platelet counts < 2010 ( 9 ) / L , there was no difference in the number of CSBEs , but the platelet transfusion rates were higher in the placebo group ( P < .0001 ) , which may have affected the overall CSBE results in this group with severe thrombocytopenia .